Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer
NCT00654030
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG:
1650-G Vaccine
Sponsor
Edward Hirschowitz
Collaborators
[object Object]